Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVE: This study aimed to evaluate the association of axillary lymph node ratio (LNR) and number of positive lymph nodes (pN) with the risk of breast cancer recurrence and death. MATERIALS AND METHODS: A retrospective cohort study of node-positive stage II and III breast cancer patients diagnosed and treated between 2008 and 2009 at the Brazilian National Cancer Institute (INCA), Brazil. Overall and disease-free survival curves for number of positive lymph nodes (pN) and lymph node ratio (LNR) risk groups were constructed using the Kaplan-Meier method and compared by the log-rank test. Multivariate analysis was performed using stepwise forward Cox regression models. RESULTS: In total, 628 women with node-positive breast cancer were included. Most patients (69.5%) had advanced clinical stage tumors (≥IIB). The median follow-up was 58 months (range: 3-92 months). The adjusted recurrence hazard of pN2 and pN3 patients was 2.47 (95% Confidence Interval [CI] 1.72-3.56) and 2.42 (1.62-3.60), respectively, compared to pN1 patients (p<0.001), while the hazard of intermediate (0.21-0.65) and high-risk (>0.65) LNR was 2.11 (1.49-3.00) and 3.19 (2.12-4.80), respectively, compared to low-risk LNR (≤0.20) patients (p<0.001). On the other hand, the hazard of death of pN2 and pN3 patients was 2.17 (1.42-3.30) and 2.41 (1.53-3.78), respectively (p<0.001), and the hazard of intermediate (0.21-0.65) and high-risk (>0.65) LNR patients was 1.70 (1.13-2.56) and 2.74 (1.75-4.28), respectively (p≤0.001). CONCLUSION: Higher pN and LNR were associated with shorter disease-free survival and overall survival times.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pereira, A. A. C., Destro, J. R., Picinin Bernuci, M., Garcia, L. F., & Rodrigues Lucena, T. F. (2020) · JMIR mHealth and uHealth · doi:10.2196/17430 · Cited by 65
Challa, B., Tahir, M., Hu, Y., Kellough, D., Lujan, G., Sun, S., Parwani, A. V., & Li, Z. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100216 · Cited by 61
Metadata
- Authors
- Department of Surgical Oncology, M. S., Tonellotto, F., Bergmann, A., Department of Clinical Research, R. C., Abrahao, K. D. S., Department of Clinical Research, R. C., Sales de Aguiar, S., Department of Clinical Research, R. C., Adeodato Bello, M., Department of Surgical Oncology, M. S., Santos Thuler, L. C., & Department of Clinical Research, R. C.
- Venue
- European Journal of Breast Health
- Publisher
- Galenos Yayinevi
- Published
- 2019-04-04
- Volume
- 15
- Issue
- 2
- Pages
- 76-84
- ISSN
- 2587-0831 (ISSN-L)
- OpenAlex
- W2933133867
- Cited by
- 170
- References
- 0
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. https://app.cochat.ai/papers/10.5152/ejbh.2019.4414
- The paper
- Department of Surgical Oncology, M. S., Tonellotto, F., Bergmann, A., Department of Clinical Research, R. C., Abrahao, K. D. S., Department of Clinical Research, R. C., Sales de Aguiar, S., Department of Clinical Research, R. C., Adeodato Bello, M., Department of Surgical Oncology, M. S., Santos Thuler, L. C., & Department of Clinical Research, R. C. (2019). Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. European Journal of Breast Health. https://doi.org/10.5152/ejbh.2019.4414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.